Paxlovid Boceprevir Intermediate CAS 565456-77-1 Assay ≥99.0%
Commercial Supply PF-07321332 Paxlovid Li-Intermediate tse Amanang le Boleng bo Phahameng
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Lebitso la Lik'hemik'hale | (1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Litlhaloso tse tšoanang | Methyl (1R,2S,5S) -6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Nomoro ea CAS | 565456-77-1 |
Nomoro ea KAtse | RF-PI318 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C9H15NO2.ClH |
Boima ba Molek'hule | 205.683 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e tšoeu ho isa ho e tšoeu |
Boitsebiso A | IR: E Tšoanang le Tšebeliso ea Lintho |
Boitsebiso B | Nako ea ho Boloka: E Ts'oana le Ntho ea Tšebeliso |
Enantiomer | ≤0.15% |
Related Impurity (ka HPLC) | |
Tšilafalo e sa Tsejoeng | ≤0.20% |
Litšila ka Kakaretso | ≤1.0% |
Metsi | ≤0.50% |
Masalla a ho Ignition | ≤0.10% |
Litšepe tse boima | ≤20ppm |
Tlhahlobo | ≥99.0% |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | Bohareng ba PF-07321332 Paxlovid (CAS 2628280-40-8) le Boceprevir (CAS 394730-60-0) |
Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) ke motsoako oa azabicyclohexane o sebelisoang ha ho lokisoa lefu la sebete la C. kokoana-hloko (HCV) NS3 serine protease inhibitor.Ke lipakeng tsa PF-07321332 Paxlovid (CAS 2628280-40-8) le Boceprevir (CAS 394730-60-0).PF-07321332 ke inhibitor e matla le e sebetsang ka molomo ea SARS-CoV 3C-like protease (3CLPRO) .PF-07321332 e shebane le vaerase ea SARS-CoV-2 mme e ka sebelisoa bakeng sa lipatlisiso tsa COVID-19.Boceprevir (INN, trade name Victrelis) ke protease inhibitor e sebelisoang e le phekolo ea hepatitis C genotype 1. E tlama sebakeng se sebetsang sa HCV nonstructural 3 NS3 (HCV).E ne e ntse e ntlafatsoa ke Schering-Plough, empa hona joale e ntse e ntlafatsoa ke Merck ho tloha ha Schering e fumanoa ka 2009. E ile ea amoheloa ke FDA ka May 13, 2011.